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Abstract 29 
Central sensitization (CS), the increased sensitivity of the central nervous system to 30 
somatosensory inputs, accounts for secondary hyperalgesia, a typical sign of several painful 31 
clinical conditions. Brain potentials elicited by mechanical punctate stimulation using flat-tip 32 
probes can provide neural correlates of CS, but their signal-to-noise ratio is limited by poor 33 
synchronisation of the afferent nociceptive input. Additionally, mechanical punctate 34 
stimulation does not activate nociceptors exclusively. In contrast, low-intensity intra-35 
epidermal electrical stimulation (IES) allows selective activation of type-II Aδ mechano-heat 36 
nociceptors (II-AMHs), and elicits reproducible brain potentials. However, it is unclear 37 
whether hyperalgesia from IES occurs and co-exists with secondary mechanical punctate 38 
hyperalgesia, and whether the magnitude of the EEG responses evoked by IES within the 39 
hyperalgesic area is increased. To address these questions, we explored the modulation of 40 
the psychophysical and EEG responses to IES by intra-epidermal injection of capsaicin in 41 
healthy human subjects. We obtained three main results. First, the intensity of the 42 
sensation elicited by IES was significantly increased in participants who developed robust 43 
mechanical punctate hyperalgesia after capsaicin injection (i.e., responders), indicating that 44 
hyperalgesia from IES co-exists with punctate mechanical hyperalgesia. Second, the N2 peak 45 
magnitude of the EEG responses elicited by IES were significantly increased after the intra-46 
epidermal injection of capsaicin in responders only. Third, a receiver-operator 47 
characteristics analysis showed that the N2 peak amplitude is clearly predictive of the 48 
presence of CS. These findings suggest that the EEG responses elicited by IES reflect 49 
secondary hyperalgesia, and therefore represent an objective correlate of CS.  50 
 51 
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New & Noteworthy 52 
Secondary mechanical punctate hyperalgesia is a cardinal sign of central sensitization (CS), 53 
an important mechanism for chronic pain. Our study demonstrates that hyperalgesia from 54 
intra-epidermal electrical stimulation coexists with mechanical punctate hyperalgesia and 55 
elicits electroencephalographic (EEG) potentials that predict the robust occurrence of 56 
punctate hyperalgesia in a human experimental model of CS. These findings inform clinical 57 
development of EEG-based biomarkers of CS. 58 
 59 
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Introduction 67 
Central sensitization (CS) refers to the increased sensitivity of the central nervous system to 68 
somatosensory inputs. CS accounts for the enhanced painful percepts elicited by nociceptive 69 
stimulation of the skin surrounding a site of tissue injury (secondary hyperalgesia) 70 
(Ringkamp et al. 2013), and it has been suggested to be an important contributor to several 71 
chronic pain states (Ji et al. 2003; Latremoliere and Woolf 2009). A cardinal sign of CS is 72 
secondary hyperalgesia to nociceptive punctate mechanical stimuli, also known as 73 
secondary mechanical punctate hyperalgesia. Such punctate stimuli, when delivered using 74 
flat-tip probes, preferentially activate the free-nerve endings of type-I Aδ mechano-heat 75 
nociceptors (I-AMH) (Magerl et al. 2001). CS is typically established by an intense activation 76 
of C-fibre skin nociceptors: the resulting afferent barrage to the dorsal horn results in a 77 
hetero-synaptic facilitation of I-AMH inputs, which substantiates secondary mechanical 78 
punctate hyperalgesia (Geber et al. 2007; Ziegler et al. 1999).  79 
Secondary mechanical punctate hyperalgesia has been quantified by measuring the brain 80 
activity using non-invasive functional neuroimaging techniques, like functional magnetic 81 
resonance imaging (fMRI) (Lee et al. 2008) and magnetoencephalography (MEG) (Maihofner 82 
et al. 2010). Given that secondary hyperalgesia is a well-established surrogate model for 83 
centrally generated hyperalgesia in chronic pain patients, such neural correlates have 84 
potential clinical and pharmaceutical applications. However, fMRI and MEG are costly and 85 
not readily available. In contrast, electroencephalography (EEG) is more affordable and 86 
routinely used in clinical practice. Moreover, previous studies have shown that punctate 87 
stimulation causing pin-prick-like pain can elicit EEG potentials, whose amplitudes reflect 88 
subjective reports of secondary mechanical punctate hyperalgesia (Davies et al. 2010; 89 
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Iannetti et al. 2013). However, there are technical and physiological constrains that may 90 
hamper clinical translation of pinprick-evoked potentials. First, the mechanical stimulus is 91 
generated by hand-held probes. The use of hand-held probes is operator dependent, which 92 
limits reproducibility of stimulus delivery. Second, given that the force exerted is driven 93 
passively by a weighted cylinder (Magerl et al. 2001), the probe needs to be held 94 
perpendicularly to both the skin and the ground, in order to ensure that a consistent force is 95 
applied. This limits the number of body territories that can be effectively stimulated. 96 
Pneumatically driven (Kohlloffel et al. 1991) or solenoid-powered (Davies et al. 2010) 97 
mechanical devices have also be described: they circumvent some of the difficulties 98 
associated with the use of hand-held probes. However, any device that relies on mechanical 99 
stimulation to activate cutaneous nociceptors remains limited by a crucial factor, the 100 
variability in skin compliance. This limits the synchronicity of nociceptor activation, 101 
introduces high variability of spatial and temporal summation at central synapses, and thus 102 
makes the estimation of response latency and amplitude difficult. Third, when using 103 
mechanical probes, the spatial location of the stimulated spot is typically changed between 104 
trials, which further increases the variability of the afferent nociceptive input. Lastly, and 105 
most importantly, mechanical punctate stimulation activates intra-epidermal nociceptive 106 
nerve endings preferentially, but not selectively. Indeed, at higher stimulus intensities the 107 
dermis and subcutaneous tissues are more likely to become temporarily deformed, which 108 
may result in a certain degree of activation of deeper Aβ afferents (Treede et al. 2002). 109 
A possible alternative to punctate stimulation is the selective activation of Aδ nociceptors by 110 
simple and affordable concentric electrodes that are designed to deliver currents exclusively 111 
to the epidermal skin layers, where the free nerve-endings of nociceptors ramify (Inui and 112 
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Kakigi 2012; Inui et al. 2002). Psychophysical, behavioural and electrophysiological data 113 
indicate that, when used at low-intensity of current, intra-epidermal electrical stimulation 114 
(IES) activates Aδ nociceptors selectively, i.e. without coactivating Aβ afferents (Mouraux et 115 
al. 2010). Still, it remains to be determined whether the psychophysical and EEG responses 116 
evoked by IES are increased in the presence of secondary mechanical punctate hyperalgesia. 117 
This question is physiologically pertinent: given the evidence that IES predominantly activate 118 
type-II AMHs (Mouraux et al. 2010; Treede and Magerl 2000), the observation that EEG 119 
responses to IES are increased would imply that hyperalgesia from IES is also mediated by 120 
this class of nociceptive afferents. 121 
Here, we explored whether IES evoked potentials hold promise as an objective neural 122 
correlate of secondary hyperalgesia. We intra-epidermally injected capsaicin in right hand of 123 
healthy subjects to induce a state of CS. Participants were classified in responders and non-124 
responders based on whether or not they developed robust secondary mechanical punctate 125 
hyperalgesia. We then tested (1) whether subjects who developed secondary mechanical 126 
hyperalgesia also developed secondary hyperalgesia from nociceptive-specific IES. We also 127 
(2) explored whether the magnitude of the EEG responses to nociceptive IES delivered to 128 
the secondary hyperalgesic area was significantly increased and (3) quantified the sensitivity 129 
and specificity of the EEG responses elicited by IES for detecting the presence of secondary 130 
hyperalgesia in our study cohort. 131 
 132 
Materials and Methods 133 
Participants  134 
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Fourteen healthy right-handed volunteers participated in this study. All participants were 135 
pain-free, not taking any medication and did not have any history of severe allergic 136 
reactions to chilli peppers at the time of testing. They all gave signed written informed 137 
consent, and the experimental procedures were approved by the UCL Research Ethics 138 
Committee. Before the electrophysiological recording, the experimental setup and the 139 
psychophysical rating task were clearly explained to the participants, who were also 140 
familiarized with the sensation elicited by IES. Data from two participants were discarded 141 
because no clear event-related potential (ERP) could be identified, and the data from the 142 
remaining twelve participants (22-39 years, 7 female) were analysed. 143 
Experimental design 144 
The experimental design is summarised in Figure 1 (upper panel). Experiments were 145 
conducted in a silent and temperature-controlled room. Throughout the experiment 146 
participants sat on a comfortable chair with the hands resting on a table in front of them. 147 
Participants were instructed to keep their gaze fixed on a black cross (2 × 2 cm) placed 148 
centrally in front of them, at a distance of 1.5 m, ~20o below eye level. To induce CS, 149 
capsaicin was injected intra-epidermally on the right hand dorsum (Ziegler et al. 1999). IES 150 
were delivered in two separate blocks, one before (‘pre-capsaicin’) and one after capsaicin 151 
injection (‘post-capsaicin’). In the post-capsaicin block, IES were delivered only after 152 
capsaicin-induced spontaneous pain had resolved. In each block we delivered 20 stimuli on 153 
the left hand dorsum and 20 stimuli on the right hand dorsum, in pseudo-random order, 154 
with an inter-stimulus interval (ISI) of 8-12 s (rectangular distribution). Therefore, there 155 
were four conditions: (1) Pre-capsaicin, right hand (PreRH); (2) Pre-capsaicin, left-hand 156 
(PreLH); (3) Post-capsaicin, right-hand (PostRH); and (4) Post-capsaicin, left-hand (PostLH). 157 
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Three seconds after the stimulus onset, subjects were asked to state whether the stimulus 158 
was delivered on the right or the left hand, and to provide ratings of the perceived intensity 159 
of pinprick pain, using a numerical scale ranging from 0 (no pinprick sensation) to 100 (the 160 
most intense pinprick sensation imaginable).  161 
Intra-epidermal electrical stimulation (IES) 162 
IES consisted of two constant-current square-wave pulses delivered in rapid succession, as 163 
described in (Inui et al. 2002; Mouraux et al. 2010). Each pulse lasted 500 µs, and the inter-164 
pulse interval was 10 ms (DS7, Digitimer, UK). Stimuli were delivered using a stainless steel 165 
concentric bipolar needle electrode, consisting of a needle cathode (length: 0.1 mm, Ø: 0.2 166 
mm) surrounded by a cylindrical anode (Ø: 1.4 mm) (Inui et al. 2002; Mouraux et al. 2010). 167 
By gently pressing the device against the skin, the needle electrode was inserted into the 168 
epidermis. Two electrodes were applied, one on the dorsum of each hand. Once the 169 
electrodes were fixed, the thresholds for stimulus perception were determined for each 170 
hand and each subject, using an adaptive staircase procedure. The final intensity of the IES 171 
for the experiment was set to twice the perceptual threshold, to ensure selective 172 
stimulation of skin nociceptors (Mouraux et al. 2010).  173 
After the thresholding procedure, we delivered a few stimuli at the intensity determined 174 
above, to familiarize the participant with the elicited sensation. If the participant reported a 175 
different perceived intensity on two hands, the location of the electrodes were adjusted on 176 
each participant until the reported intensities on both hands were similar, and then the 177 
thresholding procedure was repeated and the new stimulus intensity was determined. 178 
Capsaicin injection 179 
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To induce CS, we injected intra-epidermally a 10 mM solution of capsaicin (40 µg in a 12.5 µl 180 
volume of normal saline containing 0.16% Tween 80; for details, see (LaMotte et al. 1991). 181 
The capsaicin solution was injected at an angle of approximately 15o to the skin surface, 182 
using a 27-gauge disposable needle. The injection site was ~1.5 cm away from the IES 183 
electrode on the right hand dorsum. Therefore, IES was delivered on the skin area of 184 
secondary hyperalgesia away from the injection site where the skin would have been 185 
numbed by the local neurotoxic effects of capsaicin (LaMotte et al. 1992). 186 
Capsaicin-induced spontaneous pain and secondary hyperalgesia assessment 187 
Spontaneous pain intensity after capsaicin injection was recorded using a numerical rating 188 
scale ranging between 0 (no pain) and 100 (worst pain imaginable). Participants were 189 
required to rate verbally the intensity of spontaneous pain every 10 s during the first 3 190 
minutes and then every 30 s until the pain intensity ratings were less than 5 out of 100. 191 
The development of mechanical hyperalgesia in the skin area surrounding the injection site 192 
was confirmed by punctate mechanical stimulation of the skin adjacent (within 1 cm) to the 193 
external circumference of the concentric IES electrode, using a flat-tip punctate probe (256 194 
mN). This probe comprises a stainless steel wire tip (Ø: 0.25 mm) attached to a mounted 195 
weight (256 mN) that glides smoothly within a hollow handheld cylindrical tube. When 196 
applied perpendicularly to the skin, the weight of the probe rested entirely on the wire tip, 197 
thus exerting a constant force of 256 mN. More details and a depiction of the punctate 198 
probe can be found in (Iannetti et al. 2013), as well as in the manufacturer website (MRC 199 
Systems GmbH; http://www.mrc-systems.de/en/products/pinprick). The same mechanical 200 
stimulus was applied to the corresponding position of the left hand, to obtain a baseline for 201 
quantifying the effect of secondary hyperalgesia, as follows. Participants were asked to 202 
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report the intensity of punctate stimulation of the right hand (capsaicin-injected) and of the 203 
left hand (control), using a numerical rating scale that ranged between 0 (no pinprick 204 
sensation) and 100 (the most intense pinprick sensation imaginable). For each hand, 205 
punctate stimuli were applied three times with an inter-stimulus interval of approximately 5 206 
sec, after the spontaneous pain induced by the capsaicin injection in the right hand had 207 
decreased to less than 5 out of 100 (Figure 2). For every individual, the mean ratings of the 208 
sensations elicited by the three stimuli was obtained for each hand and condition. The 209 
intensity of secondary hyperalgesia was quantified as the ratio of the subjective ratings of 210 
the pinprick sensation elicited by mechanical stimulation of the right and the left hands 211 
(Right/Left). Participants were considered to have developed robust secondary hyperalgesia 212 
from punctate stimuli if the ratio was ≥2, and were thus classified as responders. All other 213 
participants were classified as non-responders. This ratio was chosen based on a previous 214 
EEG study, which showed that an approximately two-fold increase (+93%) in pinprick 215 
sensation elicited by punctate stimulation after capsaicin sensitisation was associated with 216 
significant increases in the evoked EEG response (Iannetti et al. 2013). 217 
EEG recording 218 
The EEG was recorded using 31 Ag-AgCl electrodes placed on the scalp according to the 219 
International 10-20 system, and referenced to the nose. Ocular movements and eye blinks 220 
were recorded using two surface electrodes, one placed over the right lower eyelid, the 221 
other placed approximately 1 cm lateral to the lateral corner of the right orbit. Signals were 222 
amplified and digitized using a sampling rate of 1,024 Hz (SD32, Micromed, Italy). 223 
Behavioural data analysis 224 
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Single trial ratings of the sensation elicited by IES were first normalized between 0 and 100, 225 
for each participant (the minimum value was set to 0 and the maximum value was set to 226 
100). This procedure mitigates the differences in the range of values on the numerical rating 227 
scale with which individuals reported the intensity of pinprick pain elicited by IES (Huang et 228 
al. 2013). Normalized stimulus intensity ratings were subsequently averaged across trials for 229 
each condition, resulting in four average values for each participant (PreRH, PreLH, PostRH, 230 
PostLH). 231 
To test whether capsaicin injection had an effect on the perceived IES intensity, we 232 
performed a three-way ANOVA, with the following experimental factors: Group (two levels: 233 
Responders, Non-Responders), Session (two levels: Pre-capsaicin, Post-capsaicin), and Hand 234 
(two levels: Injected [Right], Control [Left]). 235 
Where effects were significant, post-hoc analyses were performed to define their direction 236 
and possible interactions. Two-way repeated-measures ANOVA for the main and interaction 237 
effects of Session and Hand were performed to define the effects of capsaicin injection on 238 
the intensity of the sensation elicited by IES, within each group. The statistical threshold of 239 
the post hoc analyses was Bonferroni corrected accounting for the number of comparisons 240 
(P = 0.05/2 = 0.025).  241 
  242 
EEG data analyses 243 
EEG data analyses were performed using Letswave (www.nocions.org) (Mouraux and 244 
Iannetti 2008) and Matlab (The MathWorks, Natick, MA). Continuous EEG recordings were 245 
segmented into epochs using a time window of 2 s (-0.5 to 1.5 s relative to the stimulus 246 
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onset). Each epoch was baseline corrected (baseline interval ranging from -0.2 to 0 s), and 247 
band-pass filtered (1–30 Hz). Artefacts produced by eye blinks or eye movements were 248 
subtracted using a validated method based on independent component analysis (Jung et al. 249 
2000). In all data sets, independent components related to eye movements had a large 250 
electrooculogram channel contribution and a frontal scalp distribution. In addition, epochs 251 
with amplitude values exceeding ±100 µV were rejected from further analysis. These epochs 252 
constituted 0.6 ±1.8% (mean ±SD across all conditions and participants) of the total number 253 
of epochs. Remaining epochs were then averaged for each condition, resulting in four 254 
average ERP waveforms for each participant.  255 
The N2-P2 complex was measured at the vertex (Cz), and it was defined as the largest 256 
negative-positive deflection occurring after stimulus onset. The amplitude of both the N2 257 
and P2 peaks were calculated for each condition and participant, and tested for the effect of 258 
capsaicin injection, using the same three-way ANOVA described for the behavioural data 259 
(Figure 1, lower panel). As two peaks (N2 and P2) were tested, the statistical threshold, P = 260 
0.05/2 peaks = 0.025, was determined by Bonferroni correction accounting for the number 261 
of peaks. Where effects were significant, the same post-hoc analyses described for the 262 
behavioural data (i.e., two-way repeated measures ANOVA) were performed for each group, 263 
and the same statistical threshold, Bonferroni corrected (P = 0.05/2 groups = 0.025), was 264 
used to determine the significance of the post-hoc results. The latency of the N2 and P2 265 
peaks were analysed using the same procedure.    266 
To test the predictive value of ERP amplitude for the presence of central sensitisation, we 267 
plotted the receiver operating characteristic (ROC) curves obtained using the interaction 268 
term (i.e. (PostRH-PreRH)-(PostLH-PreLH)) calculated for the N2-wave and P2-wave peak 269 
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amplitudes. The true positive rate (Sensitivity) is plotted against the false positive rate (100-270 
Specificity) for different cut-off values of the interaction terms. Each point on the ROC curve 271 
represents a sensitivity/specificity pair corresponding to a particular decision threshold for 272 
the interaction term. Above each of these thresholds the individual is predicted to be a 273 
responder, and vice versa. If interaction terms had perfect classification performance, their 274 
ROC curves would pass through the upper left corner (100% sensitivity, 100% specificity). 275 
The closer the ROC curve is to the upper left corner, the higher the overall accuracy of the 276 
interaction term is in distinguishing responders and non-responders (Zweig and Campbell 277 
1993). The Area Under Curve (AUC) is typically used to quantify the classification 278 
performance. An AUC value of 0.5 corresponds to a random classification (i.e. to a useless 279 
test), whereas an AUC of 1.0 indicates that the test performs perfectly. We calculated the 280 
AUC for the interaction terms obtained from the amplitude of the N2 and P2 peaks, to 281 
assess their sensitivity and specificity for detecting the presence of a CS state. We tested 282 
whether the AUC size of each measure was significantly greater than 0.5 (Hanley and McNeil 283 
1982).  284 
 285 
Results 286 
Six out of twelve participants developed robust secondary hyperalgesia on the capsaicin-287 
treated hand and were therefore classified as responders (Figure 2, upper panel).  288 
Capsaicin-induced spontaneous pain 289 
The time courses of the capsaicin-induced pain for all subjects are shown in the lower panel 290 
of Figure 2. In the first few seconds after the injection, capsaicin induced a very intense 291 
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sensation of burning pain, which decreased exponentially over time (Lee et al. 2008; Magerl 292 
et al. 1998). The time course of spontaneous pain ratings for each subject was summarised 293 
as area-under-curve (AUC). The AUC for responders and non-responders were compared 294 
using a two-sample t test. The result showed no significant difference in capsaicin-induced 295 
spontaneous pain between the two groups (T10 = 0.39, P = 0.70). This observation suggests 296 
that both groups perceived the conditioning stimulus (i.e. the intra-epidermal injection of 297 
capsaicin) similarly. 298 
 299 
Psychophysics of intra-epidermal stimulation of the area of secondary mechanical 300 
punctate hyperalgesia 301 
All subjects correctly reported whether the IES was delivered to the right or to the left hand, 302 
in all trials. The three-way ANOVA on the subjective ratings of perceived IES intensity 303 
showed a two-way interaction between Group and Hand (F1,10 = 9.02, P = 0.01), and more 304 
importantly, a clear three-way interaction between Group, Session and Hand (F1,10 = 59.27, 305 
P = 0.000016) (Figure 3). No other significant effects were detected (Table 1). This finding 306 
indicates that right hand stimulation was perceived as more painful than left hand 307 
stimulation in the responders, but only after capsaicin was injected in the right hand. The 308 
results of all post hoc two-way ANOVAs are shown in Table 2. Both responders (F1,5 = 49.79, 309 
P = 0.001) and non-responders (F1,5 = 15.19, P = 0.01) showed significant interactions 310 
between Session and Hand, but in opposite directions – the responders had clearly 311 
increased ratings on their treated hand after capsaicin injection, while the non-responders 312 
showed mildly decreased ratings on their treated hand after capsaicin injection (Figure 3). 313 
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The results demonstrate a clear secondary hyperalgesia from both IES and mechanical 314 
punctate stimulation after capsaicin injection. 315 
 316 
ERP waveforms 317 
ERPs elicited by IES stimuli showed a clear N2-P2 complex maximal at electrode Cz, in all 318 
four conditions of each group. Grand-average waveforms and scalp maps at N2 and P2 peak 319 
latencies are shown in Figure 4. The ERP amplitude increased after capsaicin injection in the 320 
right hand of the responders, compared with all other conditions. Statistical comparisons of 321 
peak amplitude and latency of the N2 and P2 waves across different conditions and groups 322 
are reported below, and summarized in Tables 1 and 2.  323 
N2 peak amplitude. The three-way ANOVA of N2 peak amplitudes showed a three-way 324 
interaction between Group, Session and Hand (F1,10 = 7.84, P = 0.019). No other significant 325 
effects were detected (Table 1). Hence, N2 peak amplitudes at Cz were greater following 326 
right-hand IES compared to left-hand IES in the responders, but only when IES were 327 
delivered to the hand where capsaicin had been injected (i.e. the right hand). Post hoc two-328 
way ANOVAs (Table 2) revealed that only responders showed an interaction between 329 
Session and Hand (F1,5 = 15.15, P = 0.011) indicating increased N2 amplitudes on their 330 
treated hand after capsaicin injection. Figure 5 shows the single-subjects N2 peak 331 
amplitudes, as well as the statistical results. 332 
P2 peak amplitude. The three-way ANOVA of P2 peak amplitudes showed that there was a 333 
two-way interaction between Group and Session (F1,10 = 11.13, P = 0.008). This effect was 334 
caused by an overall increased P2 amplitude in the post-capsaicin session of responders, but 335 
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a decreased P2 amplitude in the post-capsaicin session of non-responders. No other 336 
significant effects were detected (Table 1). Post hoc two-way ANOVAs (Table 2) showed that 337 
there was a trend for an interaction between Session and Hand which, however, did not 338 
survive correction for multiple comparisons in responders (F1,5 = 9.77, P = 0.026): in this 339 
group, P2 amplitudes in the post-capsaicin session were, compared to the pre-capsaicin 340 
session, increased following right hand stimulation and slightly decreased following left 341 
hand stimulation.  342 
N2 peak latency. The three-way ANOVA of N2 peak latencies showed a main effect of Hand 343 
(F1,10 = 7.41, P = 0.022). No other significant effects were detected (Table 1). Post hoc two-344 
way ANOVAs (Table 2) fail to detect any effects in either responders or non-responders that 345 
survived correction for multiple comparisons.  346 
P2 peak latency. The three-way ANOVA on the P2 peak latencies did not detect any 347 
significant effect. Therefore, post hoc analyses were not performed.  348 
ROC curves. The ROC curves obtained from N2 and P2 peak amplitudes are plotted in Figure 349 
6. The AUC (±standard error) for N2 and P2 were 0.92 ±0.09 and 0.72 ±0.16, respectively. 350 
Only the AUC for N2 was significantly greater than 0.5 (N2: P = 0.016; P2: P = 0.200). This 351 
suggests that the N2 peak amplitude has adequate sensitivity and specificity for detecting 352 
the presence of CS induced by intra-epidermal injection of capsaicin. 353 
 354 
 355 
Discussion 356 
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Developing a biomarker for secondary hyperalgesia, a cardinal symptom of central 357 
sensitization (CS), would be useful for both drug discovery and clinical therapy. Such a 358 
biomarker would help analgesic drug discovery in early phase trials, facilitate diagnosis of 359 
neuropathic pain, and allow objective monitoring of drug treatments in patients.  360 
IES is a technically simple and inexpensive method to selectively stimulate type II Aδ skin 361 
nociceptors (Inui and Kakigi 2012; Inui et al. 2002; Mouraux et al. 2010). Importantly, IES 362 
elicits clear time-locked EEG responses, thus allowing quantification of CS. However, 363 
mechanical punctate hyperalgesia is known to be mediated by I-AMH units, rather than II-364 
AMH units (Magerl et al. 2001). Given that IES selectively activates II-AMH units (Mouraux et 365 
al. 2010), we tested (1) whether secondary hyperalgesia from IES co-exists with secondary 366 
mechanical punctate hyperalgesia, and (2) whether such hyperalgesia is reflected in a 367 
corresponding increase in EEG responses. 368 
We obtained several interesting results. First, the intensity of the sensation elicited by IES 369 
was significantly increased after intra-epidermal injection of capsaicin in those participants 370 
who developed robust mechanical punctate hyperalgesia – clearly showing that 371 
hyperalgesia from IES occurs and coexists with mechanical hyperalgesia. Second, the peak 372 
amplitude of the N2 wave elicited by IES was significantly increased in responders, similarly 373 
to the intensity of the sensation elicited by IES. This increased respons only occurred when 374 
IES were delivered to the hand where capsaicin was injected. Third, ROC analysis showed 375 
that the N2 peak amplitude offers the ability to predict the presence of CS with high 376 
sensitivity and specificity. These findings suggest that the EEG responses elicited by IES 377 
reflect secondary hyperalgesia and thus are a reliable neural correlate of CS.  378 
 379 
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Peripheral afferents mediating secondary hyperalgesia from IES 380 
Whilst our observations clearly indicate that secondary hyperalgesia elicited by IES appears 381 
to co-exist with secondary hyperalgesia elicited by mechanical punctate stimuli, it remains 382 
unclear whether the two phenomena are mediated by similar populations of Aδ 383 
nociceptors. There is strong physiological evidence that secondary mechanical punctate 384 
hyperalgesia is mediated by I-AMH nociceptors. For example, Magerl and colleagues (2001) 385 
demonstrated that secondary mechanical punctate hyperalgesia still occurs in skin that was 386 
rendered devoid of II-AMH epidermal terminals by application of high concentrations of 387 
topical capsaicin (Magerl et al. 2001). In contrast, Mouraux and colleagues (2010) showed 388 
that both sensations and EEG responses elicited by IES were abolished in skin that was 389 
similarly treated with high-concentration capsaicin, suggesting that IES activates mostly II-390 
AMH nociceptors (Mouraux et al. 2010). It follows that the secondary hyperalgesia from IES 391 
observed in this study is likely to be mediated mainly by II-AMH, rather than I-AMH 392 
nociceptors. However, further experiments are required to confirm whether hyperalgesia 393 
from IES and mechanical punctate stimulation are truly mediated by different populations of 394 
Aδ afferents. Nonetheless, it is plausible that, after capsaicin injection, inputs from both I-395 
AMH and II-AMH nociceptors are heterosynaptically facilitated via a common central 396 
mechanism, and account for the co-existence of secondary hyperalgesia from IES and 397 
mechanical punctate stimulation (Ziegler et al. 1999).  398 
Variability in capsaicin-induced secondary hyperalgesia  399 
We observed considerable variability in the degree of punctate hyperalgesia that developed 400 
after intra-epidermal capsaicin injection. Only half of the subjects developed robust 401 
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punctate hyperalgesia (i.e. a two-fold increase of pain ratings when stimulating the injected 402 
hand with respect to the control hand; Figure 2).  403 
It is unlikely that this difference between responders and non-responders was related to the 404 
strength of conditioning stimulus, i.e., the activation of C-nociceptors by intra-epidermal 405 
injection of capsaicin. Indeed, both groups reported similar intensities and durations of 406 
burning pain following intra-epidermal injection of capsaicin, which suggests that the 407 
conditioning stimulus was similar for both groups. We note that the development of 408 
secondary hyperalgesia can be highly variable even with a highly standardized electrical 409 
conditioning stimulus, which suggests considerable differences in the development of CS 410 
responses between individuals (Pfau et al. 2011). Furthermore, there is clear evidence that 411 
genetic variability contributes to variability in hyperalgesic response following intra-412 
epidermal capsaicin injection (Tegeder et al. 2008). 413 
Brain potentials evoked by IES and central sensitization: advantages and limitations 414 
Previous studies have suggested that brain potentials elicited by punctate mechanical 415 
stimulation may be recorded and employed as a potential objective correlates of the CS 416 
states (Davies et al. 2010; Iannetti et al. 2013; Kohlloffel et al. 1991). However, as detailed in 417 
the Introduction, evoked potentials elicited by punctate mechanical stimuli have significant 418 
technical and physiological constrains that may hamper clinical translation. 419 
In contrast, IES have several advantages over mechanical punctate stimulation. When 420 
delivered at low currents, they are fully selective for Aδ nociceptors, and allow for accurate 421 
timing and standardization of stimuli. The stimulating electrode is affordable and can be 422 
affixed to any part of the body without difficulty.  423 
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The current results show that the amplitude of the ERP elicited by IES of the skin with 424 
secondary hyperalgesia clearly reflects that the somatosensory system is centrally 425 
sensitised. The amplitude of the N2 wave was significantly larger when IES were delivered to 426 
the hand in which capsaicin injection resulted in a clear secondary hyperalgesia (Figures 4 427 
and 5, Tables 1 and 2). Moreover, the areas under the ROC curves indicate that the change 428 
in N2 peak amplitude was significantly predictive of the presence of secondary hyperalgesia 429 
(Figure 6). This result suggests that the changes in N2 amplitude may be developed as a 430 
potentially useful biomarker of CS. 431 
Several limitations to IES remain. First, we were unable to isolate the early, contralateral N1 432 
wave typically observed in the brain potentials evoked by nociceptive laser stimuli (Treede 433 
et al. 1988; Valentini et al. 2012), most likely because of its lower signal-to-noise ratio. 434 
Compared to the subsequent N2-P2 complex, the N1 wave has been shown to better reflect 435 
the afferent nociceptive drive (Lee et al. 2009) and appears less susceptible to top-down 436 
modulation, for example placebo manipulation (Martini et al. 2015). These characteristics 437 
make the N1 wave a potentially more robust marker for central sensitisation. Second, the 438 
selective activation of Aδ nociceptors by IES relies on the use of strictly low-intensity 439 
currents. This limitation prevents recording stimulus response functions, as higher-intensity 440 
currents necessarily entail a coactivation of tactile Aβ afferents, and therefore a loss of 441 
specificity for Aδ fibre stimulation (Mouraux et al. 2010). Stimulus response functions are 442 
particularly useful when assessing the analgesic potential of novel drugs as they can divulge 443 
interactions between stimulus or pain intensity and dose effects. Recording of stimulus 444 
response function using the brain response elicited by mechanical punctate stimuli is 445 
similarly problematic because, as detailed earlier, when high forces are exerted the 446 
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mechanical punctate stimulus becomes less selective for Aδ fibre activation (Treede et al. 447 
2002; van den Broeke et al. 2015). More recent data reveal that stimulus response functions 448 
can be constructed using IES, by varying the number of pulses delivered in quick succession 449 
(5 ms intervals) to normal skin – increasing the number of pulses increases the intensity of 450 
sensation and EEG amplitudes without changing reaction times or response latencies 451 
(Mouraux et al. 2014). Further experiments are required to ascertain if this remains the case 452 
after capsaicin-induced hyperalgesia. Moreover, although our present results suggest the 453 
potential usefulness of EEG responses to IES as an objective measure of CS, the small sample 454 
size used in the present study limits statistical power for detection of smaller effects. Future 455 
studies with large samples are needed to confirm the predictive value of IES brain potentials 456 
for the state of CS.  457 
Conclusion 458 
Our study demonstrates that secondary hyperalgesia to IES occurs in a well-recognized 459 
experimental model of CS, and that the subjective report was corroborated by increased 460 
evoked EEG responses. These findings suggest that EEG responses elicited by low-intensity 461 
IES, particularly the change in the peak amplitude of the N2 wave, can be used as an 462 
objective, physiological correlate of secondary hyperalgesia. Hence, IES evoked potentials 463 
hold promise as a low-cost non-invasive biomarker for CS that can be translated for clinical 464 
use with relative ease compared to existing techniques. 465 
 466 
 467 
  468 
22 
 
Acknowledgments 469 
This work was funded by the Wellcome Trust Pain Consortium (COLL JLARAXR to GDI and 470 
AHD), a UCL Grand Challenges studentship (to JON), the National Natural Science 471 
Foundation of China (81571659 to ML) and the Natural Science Foundation of Tianjin 472 
(15JCYBJC55100 to ML). The authors declare no conflicts of interest. 473 
474 
23 
 
References 475 
Davies EK, Boyle Y, O'Donnell M, Dalton Z, Lumb BM, Murrell JC, and Chizh BA. Evaluation of 476 
somatic mechanical-evoked potentials (MEPS) as objective neurophysiological markers of pain. In: 477 
13th World Congress on Pain. Montreal: 2010. 478 
Geber C, Fondel R, Kramer HH, Rolke R, Treede RD, Sommer C, and Birklein F. Psychophysics, flare, 479 
and neurosecretory function in human pain models: capsaicin versus electrically evoked pain. J Pain 480 
8: 503-514, 2007. 481 
Hanley JA, and McNeil BJ. The meaning and use of the area under a receiver operating characteristic 482 
(ROC) curve. Radiology 143: 29-36, 1982. 483 
Huang G, Xiao P, Hung YS, Iannetti GD, Zhang ZG, and Hu L. A novel approach to predict subjective 484 
pain perception from single-trial laser-evoked potentials. Neuroimage 81: 283-293, 2013. 485 
Iannetti GD, Baumgartner U, Tracey I, Treede RD, and Magerl W. Pinprick-evoked brain potentials: 486 
a novel tool to assess central sensitization of nociceptive pathways in humans. J Neurophysiol 110: 487 
1107-1116, 2013. 488 
Inui K, and Kakigi R. Pain perception in humans: use of intraepidermal electrical stimulation. Journal 489 
of neurology, neurosurgery, and psychiatry 83: 551-556, 2012. 490 
Inui K, Tran TD, Hoshiyama M, and Kakigi R. Preferential stimulation of Adelta fibers by intra-491 
epidermal needle electrode in humans. Pain 96: 247-252, 2002. 492 
Ji RR, Kohno T, Moore KA, and Woolf CJ. Central sensitization and LTP: do pain and memory share 493 
similar mechanisms? Trends Neurosci 26: 696-705, 2003. 494 
Jung TP, Makeig S, Humphries C, Lee TW, McKeown MJ, Iragui V, and Sejnowski TJ. Removing 495 
electroencephalographic artifacts by blind source separation. Psychophysiology 37: 163-178, 2000. 496 
Kohlloffel LU, Koltzenburg M, and Handwerker HO. A novel technique for the evaluation of 497 
mechanical pain and hyperalgesia. Pain 46: 81-87, 1991. 498 
24 
 
LaMotte RH, Lundberg LE, and Torebjork HE. Pain, hyperalgesia and activity in nociceptive C units in 499 
humans after intradermal injection of capsaicin. J Physiol 448: 749-764, 1992. 500 
LaMotte RH, Shain CN, Simone DA, and Tsai EF. Neurogenic hyperalgesia: psychophysical studies of 501 
underlying mechanisms. J Neurophysiol 66: 190-211, 1991. 502 
Latremoliere A, and Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central 503 
neural plasticity. J Pain 10: 895-926, 2009. 504 
Lee MC, Mouraux A, and Iannetti GD. Characterizing the Cortical Activity through Which Pain 505 
Emerges from Nociception. J Neurosci 29: 7909-7916, 2009. 506 
Lee MC, Zambreanu L, Menon DK, and Tracey I. Identifying brain activity specifically related to the 507 
maintenance and perceptual consequence of central sensitization in humans. J Neurosci 28: 11642-508 
11649, 2008. 509 
Magerl W, Fuchs PN, Meyer RA, and Treede RD. Roles of capsaicin-insensitive nociceptors in 510 
cutaneous pain and secondary hyperalgesia. Brain 124: 1754-1764, 2001. 511 
Magerl W, Wilk SH, and Treede RD. Secondary hyperalgesia and perceptual wind-up following 512 
intradermal injection of capsaicin in humans. Pain 74: 257-268, 1998. 513 
Maihofner C, Jesberger F, Seifert F, and Kaltenhauser M. Cortical processing of mechanical 514 
hyperalgesia: a MEG study. Eur J Pain 14: 64-70, 2010. 515 
Martini M, Lee MC, Valentini E, and Iannetti GD. Intracortical modulation, and not spinal inhibition, 516 
mediates placebo analgesia. Eur J Neurosci 41: 498-504, 2015. 517 
Mouraux A, and Iannetti GD. Across-trial averaging of event-related EEG responses and beyond. 518 
Magn Reson Imaging 26: 1041-1054, 2008. 519 
Mouraux A, Iannetti GD, and Plaghki L. Low intensity intra-epidermal electrical stimulation can 520 
activate Adelta-nociceptors selectively. Pain 150: 199-207, 2010. 521 
Mouraux A, Marot E, and Legrain V. Short trains of intra-epidermal electrical stimulation to elicit 522 
reliable behavioral and electrophysiological responses to the selective activation of nociceptors in 523 
humans. Neurosci Lett 561: 69-73, 2014. 524 
25 
 
Pfau DB, Klein T, Putzer D, Pogatzki-Zahn EM, Treede RD, and Magerl W. Analysis of hyperalgesia 525 
time courses in humans after painful electrical high-frequency stimulation identifies a possible 526 
transition from early to late LTP-like pain plasticity. Pain 152: 1532-1539, 2011. 527 
Ringkamp M, Raja SN, Campbell JN, and Meyer RA. Peripheral Mechanisms of Cutaneous 528 
Nociception. In: Wall and Melzack's textbook of pain, edited by McMahon S, Koltzenburg M, Tracey 529 
I, and Turk DCElsevier, 2013. 530 
Tegeder I, Adolph J, Schmidt H, Woolf CJ, Geisslinger G, and Lotsch J. Reduced hyperalgesia in 531 
homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain 12: 1069-1077, 2008. 532 
Treede RD, Kief S, Holzer T, and Bromm B. Late somatosensory evoked cerebral potentials in 533 
response to cutaneous heat stimuli. Electroencephalogr Clin Neurophysiol 70: 429-441, 1988. 534 
Treede RD, and Magerl W. Multiple mechanisms of secondary hyperalgesia. Prog Brain Res 129: 535 
331-341, 2000. 536 
Treede RD, Rolke R, Andrews K, and Magerl W. Pain elicited by blunt pressure: neurobiological basis 537 
and clinical relevance. Pain 98: 235-240, 2002. 538 
Valentini E, Hu L, Chakrabarti B, Hu Y, Aglioti SM, and Iannetti GD. The primary somatosensory 539 
cortex largely contributes to the early part of the cortical response elicited by nociceptive stimuli. 540 
Neuroimage 59: 1571-1581, 2012. 541 
van den Broeke EN, Mouraux A, Groneberg AH, Pfau DB, Treede RD, and Klein T. Characterizing 542 
pinprick-evoked brain potentials before and after experimentally induced secondary hyperalgesia. J 543 
Neurophysiol 114: 2672-2681, 2015. 544 
Ziegler EA, Magerl W, Meyer RA, and Treede RD. Secondary hyperalgesia to punctate mechanical 545 
stimuli. Central sensitization to A-fibre nociceptor input. Brain 122 ( Pt 12): 2245-2257, 1999. 546 
Zweig MH, and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation 547 
tool in clinical medicine. Clin Chem 39: 561-577, 1993. 548 
  549 
26 
 
Figure legends 550 
Figure 1. Upper panel. Experimental design. The state of central sensitization was induced 551 
by intra-epidermal injection of capsaicin (red arrow on the timeline). Capsaicin-induced 552 
spontaneous pain lasted between 8 and 35 minutes, during which pain ratings were 553 
collected every 10 s during the first 3 minutes and then every 30 s until the pain intensity 554 
ratings were less than 5 out of 100 (red box). Psychophysical and EEG responses to IES were 555 
collected before capsaicin injection (i.e., pre-capsaicin session, green box) and after 556 
capsaicin induced spontaneous pain had disappeared (i.e., post-capsaicin session, blue box). 557 
The development of secondary hyperalgesia to punctate mechanical stimuli was assessed by 558 
the ratio of the subjective intensity ratings of the sensation evoked by stimulation of the 559 
right and the left hand (Right/Left) (purple arrow on the timeline). Participants were 560 
considered responders if the ratio was ≥2, and non-responders otherwise. Lower panel. 561 
Schematic of the statistical analysis. A three-way ANOVA, with the factors of Group 562 
(responders, non-responders), Session (pre-capsaicin, post-capsaicin) and Hand (left, right), 563 
was used to analyse both psychophysical and ERP responses. The three-way interaction 564 
(Group x Session x Hand) indicated the effect of central sensitization on these responses. 565 
Further post hoc two-way ANOVAs with the factors of Session and Hand were performed to 566 
define the effect within each group.  567 
 568 
Figure 2. Upper panel. Participants were divided into two groups according to the ratio of 569 
probe ratings to punctate stimulation of the right and left hands: participants who rated the 570 
intensity of right hand stimulation as at least twice that of the left hand stimulation were 571 
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classified as responders. Participants were sorted by the ratio of reported intensity ratings, 572 
in descending order. Lower panel. Time course of capsaicin-induced pain ratings. Single 573 
participants are colour coded. Solid lines indicate responders. All participants rated the pain 574 
intensity between 90 and 100 at the moment of the injection. Pain ratings decreased fairly 575 
quickly over time. Upper-right inset. The comparison of the mean area under curve (AUC) 576 
between responders and non-responders revealed no significant difference (T10 = 0.39, P = 577 
0.70). Coloured symbols indicate single-subject AUC data. 578 
 579 
Figure 3. Subjective intensity ratings of the sensation elicited by the IES (Intra-epidermal 580 
Electrical Stimulation) of responders (left column) and non-responders (right column). 581 
Upper panel: to highlight the interaction between the factors Session and Hand, the 582 
subtracted ratings (Post minus Pre capsaicin injection) are shown for each hand. Colored 583 
dots indicate single subjects, and the black dots indicate the group average of each 584 
condition. Two-way ANOVA revealed that responders had a highly significant interaction 585 
between the factors Session and Hand. This reveals a capsaicin-induced increase of IES 586 
ratings (Post-Pre) on the right hand. In contrast, in non-responders the two-way ANOVA 587 
revealed a decrease of IES ratings on the right hand compared to those on the left hand. 588 
These differences in the capsaicin effect on IES ratings between responders and non-589 
responders were confirmed by the three-way ANOVA, which revealed a highly significant 590 
triple interaction (Group x Session x Hand; the comparison between the left and the right 591 
columns). LH: left hand; RH: right hand. Lower panel: individual values (colored dots) and 592 
mean value (the black dots) of each condition. PreLH: Pre-capsaicin, left hand; PostLH: Post-593 
capsaicin, left hand; PreRH: Pre-capsaicin, right hand; PostRH: Post-capsaicin, right hand. 594 
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 595 
Figure 4. Group-average ERP waveforms and scalp maps elicited by IES in responders (left 596 
panel) and non-responders (right panel). Waveforms at the channel Cz in different 597 
conditions are shown in different color. The ERP elicited by IES stimuli clearly increased after 598 
capsaicin injection only on the right hand in responders. Scalp maps at the N2 peak latencies 599 
show a central distribution, slightly lateralized to the hemisphere contralateral to the 600 
stimulated hand, maximal at the vertex (upper part of each panel). Scalp maps at the P2 601 
peak latencies show a central distribution, maximal at the vertex (lower part of each panel). 602 
The color bar shows the ERP amplitude in scalp maps.  603 
 604 
Figure 5. ERP amplitudes (N2) of IES of responders (left column) and non-responders (right 605 
column). Upper panel: to highlight the interaction between Session and Hand in each group, 606 
the subtracted ERP amplitudes (Post minus Pre capsaicin injection) are shown for each hand. 607 
Colored dots indicate single subjects, and the black dots indicate the group average of each 608 
condition. Two-way ANOVA revealed that responders had a significant interaction between 609 
the factors Session and Hand. This reveals a capsaicin-induced increase of IES ERP 610 
amplitudes (Post-Pre) on the right hand. In contrast, in non-responders the two-way ANOVA 611 
did not show any significant effect. These differences in the capsaicin effect on ERP 612 
amplitudes between responders and non-responders were confirmed by the three-way 613 
ANOVA, which revealed a significant triple interaction (Group x Session x Hand; the 614 
comparison between the left and the right columns). LH: left hand; RH: right hand. Lower 615 
panel: individual values (colored dots) and mean value (the black dot) of each condition. 616 
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PreLH: Pre-capsaicin, left hand; PostLH: Post-capsaicin, left hand; PreRH: Pre-capsaicin, right 617 
hand; PostRH: Post-capsaicin, right hand. 618 
 619 
Figure 6. ROC curves and their corresponding area under curve (AUC) obtained using the 620 
interaction term for N2 peak amplitude (left panel) and P2 peak amplitude (right panel) as 621 
the predictive factor. Although both measures show predictive ability, only the AUC of N2 622 
ROC was significantly greater than 0.5, indicating that it is therefore a predictor for the state 623 
of central sensitisation.   624 
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Table 1. Results of the three-way ANOVA of the psychophysical and EEG responses elicited 625 
by intraepidermal electrical stimulation (IES). 626 
3-way ANOVA Pain intensity 
ratings 
ERP peak amplitude ERP peak latency 
N2 P2 N2 P2 
Main effect of 
Group 
F1,10 = 0.20 
P = 0.665 
F1,10 = 0.08
P = 0.778 
F1,10 = 0.15
P = 0.705 
F1,10 = 0.008
P = 0.930 
F1,10 = 1.51 
P = 0.247 
Main effect of 
Session 
F1,10 = 0.05 
P = 0.833 
F1,10 = 0.26
P = 0.618 
F1,10 = 2.65
P = 0.134 
F1,10 = 0.50
P = 0.498 
F1,10 = 0.38 
P = 0.553 
Main effect of 
Hand 
F1,10 = 4.52 
P = 0.059 
F1,10 = 1.60
P = 0.234 
F1,10 = 0.52
P = 0.487 
F1,10 = 7.41
P = 0.022 
F1,10 = 0.11 
P = 0.742 
2-way interaction  
Group x Session 
F1,10 = 3.04 
P = 0.112 
F1,10 = 1.40
P = 0.265 
F1,10 = 11.13
P = 0.008 
F1,10 = 0.05
P = 0.827 
F1,10 = 0.53 
P = 0.484 
2-way interaction  
Group x Hand 
F1,10 = 9.02 
P = 0.013 
F1,10 = 0.45
P = 0.517 
F1,10 = 1.42
P = 0.261 
F1,10 = 0.11
P = 0.751 
F1,10 = 0.0003
P = 0.987 
2-way interaction  
Session x Hand 
F1,10 = 4.31 
P = 0.065 
F1,10 = 0.19
P = 0.674 
F1,10 = 1.27
P = 0.286 
F1,10 = 4.33
P = 0.064 
F1,10 = 1.19 
P = 0.301 
3-way interaction  
Group x Session x 
Hand 
F1,10 = 59.27 
P = 0.000016 
F1,10 = 7.84
P = 0.019 
F1,10 = 2.04
P = 0.184 
F1,10 = 0.37
P = 0.559 
F1,10 = 0.06 
P = 0.813 
Significant effects are highlighted in bold.  627 
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Table 2. Psychophysical and EEG responses elicited by IES for each condition, and results of 628 
the post hoc two-way ANOVAs for each group. 629 
Group PreRH 
(Mean 
±SD) 
PostRH 
(Mean 
±SD) 
PreLH
(Mean 
±SD) 
PostLH
(Mean 
±SD) 
Main Effect of 
Session 
(Pre vs. Post) 
Main effect of 
Hand 
(LH vs. RH) 
Interaction
Session x Hand 
Pain intensity ratings 
Responders 39.0 
±21.3 
73.3 
±15.9 
41.5
±27.1 
29.0
±16.3 
F1,5 = 0.87
P = 0.394 
F1,5 = 11.59 
P = 0.019 
F1,5 = 49.79
P = 0.0009 
Non-
Responders 
61.5 
±15.7 
34.1 
±20.0 
51.6
±23.6 
51.1
±25.3 
F1,5 = 2.90
P = 0.150 
F1,5 = 0.44
P = 0.535 
F1,5 = 15.19
P = 0.011 
N2 peak amplitudes 
Responders -8.6 
±4.4 
-14.0 
±6.4 
-9.9
±5.4 
-8.9
±5.1 
F1,5 = 1.66
P = 0.254 
F1,5 = 2.55
P = 0.171 
F1,5 = 15.15
P = 0.012 
Non-
Responders 
-12.9 
±5.5 
-9.7 
±5.1 
-10.0
±6.2 
-11.5
±2.1 
F1,5 = 0.20
P = 0.676 
F1,5 = 0.14
P = 0.723 
F1,5 = 1.69
P = 0.250 
P2 peak amplitudes 
Responders 7.9 
±2.3 
10.6 
±2.5 
8.3
±3.5 
7.6
±1.4 
F1,5 = 4.32
P = 0.092 
F1,5 = 1.87
P = 0.230 
F1,5 = 9.77
P = 0.026 
Non-
Responders 
10.7 
±3.6 
7.4 
±4.2 
10.8
±3.2 
7.9
±3.8 
F1,5 = 7.42
P = 0.042 
F1,5 = 0.11
P = 0.755 
F1,5 = 0.03
P = 0.875 
N2 peak latency 
Responders 165 
±29 
136 
±16 
168
±29 
178
±47 
F1,5 = 0.68
P = 0.447 
F1,5 = 8.75
P = 0.032 
F1,5 = 5.94
P = 0.059 
Non-
Responders 
162 
±38 
147 
±47 
169
±44 
175
±39 
F1,5 = 0.08
P = 0.783 
F1,5 = 1.95
P = 0.221 
F1,5 = 0.78
P = 0.417 
   Significant effects are highlighted in bold.  630 
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